Adapthealth Corp logo

Adapthealth Corp(AHCO)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 9 days
PROFIT SINCE LAST BUY
+1.62% ▲
LAST CLOSE
$7.53
11/17/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for AHCO

11/17/2026: AHCO (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Adapthealth Corp is a national provider of home medical equipment, respiratory therapies, and specialized chronic care supplies. The company's main strengths lie in its extensive geographic footprint, deep referral networks, and a recurring revenue model built on equipment rentals and consumable resupplies. Its primary growth opportunity stems from favorable demographic aging trends and expanding capitated partnerships with major health systems. However, investors must weigh risks related to reimbursement policy pressures, debt levels, and historical bottom-line volatility. The stock may suit growth-oriented investors willing to monitor execution milestones and regulatory developments in the home healthcare sector.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile top-line revenue has expanded through acquisitions, bottom-line growth has been uneven due to integration costs and impairments.
Momentum investorStrong fit while signal remains positiveMomentum fit is conditional on a positive short-term technical upturn and trading breakout.
Value investorMixed fitThe stock trades at low price-to-sales multiples, but leveraged capital structure and earnings volatility require careful credit scrutiny.
Dividend investorWeak fitAdapthealth does not pay a cash dividend, focusing instead on debt management and capital reinvestment.
Low-risk investorWeak fitThe equity exhibits higher price volatility and regulatory sensitivity than defensive blue-chip alternatives.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock is susceptible to sharp price swings driven by quarterly earnings reports and broader healthcare sector sentiment.
Valuation riskMediumAlthough trading at modest sales multiples, sentiment can be weighed down by historical GAAP net losses.
Competition risk (HME and medical distributors)Medium / highCompetition from large national suppliers and regional health networks can pressure profit margins.
Business qualityMediumThe recurring revenue model provides solid operational foundations, but integration complexity moderates franchise quality.
Dividend incomeLow / noneIncome-focused investors receive no dividend yield from the common stock.
Execution riskMedium / highSuccessfully managing large acquired footprints and improving capitated contract margins requires disciplined execution.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.06B USD
Price to earnings Ratio -
1Y Target Price 8.86
Price to earnings Ratio -
1Y Target Price 8.86
Volume (30-day avg) 2.5M shares
Beta 1.32
52 Weeks Range 5.21 - 13.43
Updated Date 11/17/2026
52 Weeks Range 5.21 - 13.43
Updated Date 11/17/2026
Dividends yield (FY) -
Basic EPS (TTM) -3.26

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
63.9%
Active BUY / eligible
69 / 108
30-Day BUY Count Change
+31
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Devices

BUY participation
62.5%
Active BUY / eligible
5 / 8
30-Day BUY Count Change
+4

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -81.83%
Avg. Invested days 19
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/17/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
AHCO receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by soft unit economics, soft quantitative characteristics, and weak price momentum.

Company Fundamentals

★★★★★
AHCO has moderate overall fundamentals (3 stars), with moderate financial health, soft growth momentum, and solid ownership. In FY2025 versus FY2024, solid cash generation (FCF margin 6.8%) is partially offset by negative earnings growth (-178.3%), slightly negative revenue growth (-0.5%), weak profitability (net margin -2.2%).

Financial Health Rating

★★★★★
AHCO's financial health is supported by moderate cash strength, including free-cash-flow generation (6.8% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
AHCO's growth profile is soft, with the least-weak measure being revenue growth at -0.5% FY2025 versus FY2024. By comparison, while earnings growth (-178.3%, negative) and free-cash-flow growth (-7.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 105.4% and approximately 63.0% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 8.78% supports management-shareholder alignment.

Top 5 Institutional Investors

OEP CAPITAL ADVISORS, L.P. 11.95%
BlackRock Inc 11.76%
Deerfield Management Co 8.41%
SkyKnight Capital, L.P. 6.28%
FMR Inc 5.77%

Unit Economics (Per $1K Revenue)

★★★★★
AHCO generates approximately $175 of gross profit, $57 of operating income, and $68 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Soft margins explain the 2-star rating, with weak cash conversion and strong capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -335.78% (Tax Credit)

Quantitative Style Profile

★★★★★
AHCO has a liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

High VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Sleep HealthRental of CPAP/BiPAP devices and regular sales of masks, tubing, and replacement filters.This is the company's largest revenue engine, benefiting from ongoing patient needs for sleep apnea management.
Respiratory HealthProvision of home oxygen systems, ventilators, and related clinical support services.Provides steady, recurring income driven by chronic respiratory care needs among elderly patients.
Diabetes Health & Wellness at HomeContinuous glucose monitors, testing supplies, mobility devices, and wound care products.Diversifies revenue streams through specialized consumable medical supplies shipped directly to patients' homes.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Valuation

Trailing PE -
Forward PE 7.78
Enterprise Value 3.01B
Price to Sales(TTM) 0.31
Enterprise Value 3.01B
Price to Sales(TTM) 0.31
Enterprise Value to Revenue 0.88
Enterprise Value to EBITDA 27.7
Shares Outstanding 136.53M
Shares Floating 85.95M
Shares Outstanding 136.53M
Shares Floating 85.95M
Percent Insiders 8.78
Percent Institutions 105.45

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.